← FDA Drug Approvals (Drugs@FDA)
PENICILLAMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2021-10-08
Drug application
- FDA Application #
ANDA214363
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PENICILLAMINE
- Generic name
- PENICILLAMINE
- Active ingredients
- PENICILLAMINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NAVINTA LLC
- Manufacturer
- Navinta LLC
- First approval
- 2021-10-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown